Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epigenetics
Biotech
Tune Tx's $175M series B to fund epigenetic HBV therapy's trials
Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds.
James Waldron
Jan 13, 2025 8:23am
2 biotechs shed staff, fuse to form genetic medicine company
Dec 11, 2024 7:00am
Omega halts sole clinical-stage asset to focus on 3 programs
Nov 15, 2024 5:33am
Epigenetic cancer drug duo packs punch against colorectal cancer
Apr 1, 2024 3:20pm
Epigenetic silencing lasts in mice, Chroma-sponsored study shows
Feb 28, 2024 11:00am
Tune’s HBV therapy hits the right notes in cells and mice
Dec 7, 2023 2:05pm